Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 2, 2016

Primary Completion Date

July 9, 2018

Study Completion Date

June 5, 2019

Conditions

PCOS

Interventions

DRUG

Metformin and Spironolactone

Oral Metformin tablet (500 mg/tablet) twice daily for 6 months. Oral Spironolactone tablet (50 mg/tablet) once daily for 6 months.

Trial Locations (1)

Children's Mercy Hospital, Kansas City

All Listed Sponsors

lead

Children's Mercy Hospital Kansas City

OTHER

NCT03981861 - Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents | Biotech Hunter | Biotech Hunter